How to Get Finasteride in Minnesota

Prescription access and medication affordability image for How to Get Finasteride in Minnesota

At a glance

  • Legal status / prescription-only drug under federal and Minnesota law
  • Telehealth availability / yes, telehealth prescribing of finasteride is permitted in Minnesota
  • Standard doses / 1 mg daily (androgenetic alopecia), 5 mg daily (BPH)
  • Compounding / 503A licensed compounding pharmacies in Minnesota may compound finasteride
  • Medicaid coverage / covered for BPH and male pattern hair loss with prior authorization (PA)
  • Labs before starting / DHT, testosterone, PSA (age 40+), and liver function recommended
  • Time to first dose / as fast as 24 hours via telehealth plus mail-order pharmacy
  • Prescribers / MDs, DOs, NPs, and PAs are all authorized prescribers in Minnesota
  • Generic availability / yes, multiple generic manufacturers; brand name is Propecia (1 mg) or Proscar (5 mg)
  • Transfer status / out-of-state finasteride prescriptions can be transferred to a Minnesota pharmacy

What Is Finasteride and Why Do Minnesota Residents Seek It?

Finasteride is a 5-alpha-reductase type II inhibitor that reduces serum dihydrotestosterone (DHT) by approximately 65 to 70 percent within 24 hours of the first oral dose [1]. DHT is the androgen responsible for miniaturizing hair follicles in genetically susceptible men and for driving prostate enlargement in benign prostatic hyperplasia (BPH). The FDA approved finasteride 1 mg (Propecia) for male androgenetic alopecia (AGA) in 1997 and finasteride 5 mg (Proscar) for BPH in 1992 [2].

In the landmark Kaufman et al. randomized controlled trial published in the Journal of the American Academy of Dermatology (N=1,553 men over 2 years), finasteride 1 mg daily increased hair count by a mean of 11.1 hairs per square centimeter versus a loss of 0.5 hairs per square centimeter on placebo (P<0.001) [3]. Hair count improvements were maintained through 5 years of continuous use in the long-term extension arm of related Merck-sponsored trials [4].

Minnesota has roughly 5.8 million residents and a dense network of dermatology, urology, and primary care clinics in the Twin Cities metro area, plus expanding telehealth infrastructure that reaches rural counties from International Falls to Worthington [5]. Both in-person and remote pathways are legally available.

Who Can Prescribe Finasteride in Minnesota?

Any licensed prescriber holding a valid DEA registration and a Minnesota state license may write a finasteride prescription. Finasteride is not a controlled substance, so no DEA schedule restriction applies. Under Minnesota Statutes Chapter 148 and Chapter 147, the following practitioners are authorized to prescribe:

  • Medical doctors (MDs) and doctors of osteopathic medicine (DOs)
  • Nurse practitioners (NPs) holding a collaborative or independent practice agreement under Minn. Stat. § 148.235
  • Physician assistants (PAs) under a delegation agreement with a supervising physician per Minn. Stat. § 147A.18

Minnesota expanded NP independent prescriptive authority in 2014, meaning a nurse practitioner with prescriptive authority does not require a co-signature from a physician before sending a finasteride prescription to a pharmacy [6]. This makes telehealth-only NP-staffed platforms fully viable for Minnesota patients.

Dermatologists most commonly prescribe 1 mg finasteride for AGA. Urologists typically manage the 5 mg BPH dose. Primary care providers and internists prescribe both formulations frequently, and telehealth platforms typically route patients to whichever credential is on duty.

How to Get a Finasteride Prescription: Step-by-Step

Getting a finasteride prescription in Minnesota requires four practical steps regardless of whether the visit is in-person or remote.

Step 1. Choose a visit type. In-person dermatology or urology appointments in the Twin Cities typically have 3- to 6-week wait times for new patients at academic centers like the University of Minnesota Medical Center. Primary care same-day or next-day slots are more common. Telehealth platforms can complete a clinical assessment asynchronously in under 15 minutes or synchronously via video within hours.

Step 2. Complete intake and medical history. The prescribing clinician will ask about family history of prostate cancer, prior PSA values, sexual function baseline, any 5-alpha-reductase inhibitor use, liver disease history, and current medications. Providing this information accurately shortens the visit and avoids prescribing delays.

Step 3. Labs, if ordered. Not every clinician orders baseline labs, but best-practice guidelines from the American Urological Association (AUA) recommend baseline PSA before starting finasteride in men 40 and older because finasteride halves PSA values, which can mask early prostate cancer [7]. A 2023 AUA guideline update states: "Clinicians should obtain a baseline PSA value prior to initiation of 5-alpha-reductase inhibitor therapy and should use a PSA doubling correction factor of two when interpreting PSA during treatment" [7]. Labs can be ordered to a Quest or LabCorp draw site anywhere in Minnesota and results typically return within 24 to 48 hours.

Step 4. Pharmacy fulfillment. Once the prescription is sent electronically to a pharmacy, standard retail fulfillment takes 1 to 4 hours. Mail-order fulfillment via a 90-day supply typically arrives in 3 to 5 business days. Some telehealth platforms integrate directly with mail-order pharmacies and ship to any Minnesota zip code including rural areas not served by retail chains.

Telehealth Finasteride Prescribing in Minnesota

Minnesota permits synchronous video, asynchronous (store-and-forward), and telephone-based telehealth encounters for prescribing finasteride. The Minnesota Board of Medical Practice confirms that a prescribing relationship can be established through telehealth without a prior in-person visit, provided the clinician conducts a sufficient evaluation to support the prescription [8].

Platforms operating in Minnesota must hold a valid Minnesota prescriber license for each clinician seeing Minnesota patients. Federal telehealth flexibilities introduced during the COVID-19 public health emergency were extended through 2025, preserving audio-only prescribing options in some contexts, but most platforms default to video or asynchronous questionnaire models for hair loss and BPH [9].

A useful decision framework for choosing between telehealth and in-person care: if the primary concern is AGA in a man under 40 with no family history of prostate cancer and no lower urinary tract symptoms, asynchronous telehealth is clinically appropriate. If the concern is BPH with obstructive symptoms, or if PSA is elevated, an in-person urology evaluation including digital rectal exam is the more thorough first step.

Asynchronous telehealth visits for finasteride typically cost between $25 and $75 out of pocket, versus a $150 to $300 copay range for a new-patient in-person dermatology appointment, depending on insurance. Generic finasteride 1 mg (30-tablet supply) retails for $15 to $30 at most Minnesota pharmacies with a GoodRx coupon [10].

What Labs Are Needed Before Starting Finasteride in Minnesota?

Lab requirements vary by indication and patient age. No single universal protocol exists, but the following reflect current clinical standards.

For AGA (1 mg dose):

  • Baseline PSA in men 40 and older (AUA guideline recommendation) [7]
  • Total testosterone if there is clinical suspicion of hypogonadism
  • Complete metabolic panel (CMP) if there is a history of liver disease, since finasteride is hepatically metabolized via CYP3A4 [11]
  • DHT levels are not routinely required but may be measured to confirm 5-alpha-reductase inhibition at follow-up

For BPH (5 mg dose):

  • PSA at baseline and at 3 to 6 months (to establish a new personal baseline on therapy) [7]
  • Urinalysis to exclude infection or hematuria
  • Post-void residual via bladder ultrasound in patients with severe symptoms
  • Creatinine if renal obstruction is a concern

The FDA label for finasteride notes that serum PSA concentration is reduced by approximately 50 percent in patients treated with finasteride 5 mg for 6 months or more [2]. A measured PSA of 1.4 ng/mL on therapy therefore corresponds to an effective PSA of roughly 2.8 ng/mL, which is a clinically significant distinction for prostate cancer screening.

Lab work can be ordered at any of Minnesota's major draw-site networks. Minnesota has 87 counties and over 300 Quest and LabCorp locations, plus hospital outpatient lab services at M Health Fairview, Allina Health, and HealthPartners facilities statewide [5].

Finasteride Pharmacies in Minnesota: Retail, Mail-Order, and 503A Compounding

Retail pharmacies: Every major retail chain operating in Minnesota, including CVS, Walgreens, Hy-Vee Pharmacy, and Coborn's, stocks generic finasteride 1 mg and 5 mg tablets. Availability is consistent in metro areas. Rural Minnesota pharmacies, including independent pharmacies in towns with populations under 5,000, generally stock finasteride because of steady demand for BPH management.

Mail-order pharmacies: Express Scripts, OptumRx, and CVS Caremark (the three largest pharmacy benefit managers by covered lives in Minnesota employer plans) all dispense generic finasteride by mail with 90-day supplies at reduced cost-sharing [12]. Patients using telehealth platforms often receive e-prescriptions routed directly to a mail-order pharmacy the platform contracts with, which ships to any Minnesota address.

503A compounding pharmacies: Under Minnesota Board of Pharmacy regulations and the federal Drug Quality and Security Act (DQSA) of 2013, 503A pharmacies are licensed to compound finasteride for individual patients when a valid prescription and documented clinical rationale exist [13]. Compounded formulations available in Minnesota include:

  • Oral capsules at non-standard doses (e.g., 0.5 mg or 2.5 mg) for patients requiring dose titration
  • Topical finasteride solutions (commonly 0.1% to 0.25% in a vehicle such as minoxidil-finasteride combination)
  • Sublingual troches

Topical finasteride produces meaningful local DHT suppression with lower systemic absorption than oral formulations. A 2021 study published in the Journal of the American Academy of Dermatology (N=323) found that topical finasteride 0.25% solution applied once daily produced scalp DHT reduction comparable to oral finasteride 1 mg, with serum DHT suppression of only 9.3% versus 64.1% for oral (P<0.001), potentially reducing systemic side effect risk [14].

Minnesota 503A pharmacies must be licensed by the Minnesota Board of Pharmacy and comply with USP Chapter 795 standards for non-sterile compounding [15]. Patients should verify that any compounding pharmacy they use holds a current Minnesota license before accepting a shipped compound.

Minnesota Medicaid Coverage and Prior Authorization for Finasteride

Minnesota Medicaid (Medical Assistance) covers finasteride for both BPH and androgenetic alopecia, but coverage for AGA requires prior authorization (PA). The Minnesota Department of Human Services pharmacy program lists finasteride 5 mg on the preferred drug list (PDL) for BPH without PA. Finasteride 1 mg for AGA is covered under the "cosmetic" carve-out but PA is required to demonstrate medical necessity [16].

PA documentation for AGA in Minnesota typically requires:

  1. Diagnosis of androgenetic alopecia confirmed by a licensed prescriber
  2. Documentation that the hair loss is causing psychological distress or functional impairment (e.g., using a validated scale such as the Dermatology Life Quality Index)
  3. A statement that the patient has been counseled on the risk of sexual side effects and post-finasteride syndrome
  4. Prescriber attestation that the patient does not have a contraindication (pregnancy potential in the prescriber's panel, known hypersensitivity)

PA approvals for AGA on Minnesota Medicaid are typically valid for 12 months, after which re-authorization is required with documentation of treatment response [16]. Commercial insurance plans in Minnesota vary considerably: some cover 1 mg finasteride without PA, others require step therapy with minoxidil first (typically 3 to 6 months of documented minoxidil use before finasteride is approved), and others exclude cosmetic indications entirely.

Medicare Part D covers finasteride 5 mg for BPH on most formularies but typically excludes finasteride 1 mg as a cosmetic drug, consistent with the Medicare prescription drug benefit's cosmetic exclusion under 42 U.S.C. § 1395w-102 [17].

Transferring a Finasteride Prescription to Minnesota

If you are moving to Minnesota or temporarily residing there, an existing finasteride prescription from another state can be transferred to a Minnesota pharmacy. Federal law (21 U.S.C. § 353) permits pharmacies to transfer valid non-controlled prescriptions between states for a patient, provided the original prescription has remaining refills and the receiving pharmacy is licensed in Minnesota [18].

Practical steps for transfer:

  1. Contact the Minnesota pharmacy where you want to fill the prescription.
  2. Provide the name, phone number, and address of the originating pharmacy.
  3. Provide your name, date of birth, and the drug name and dose.
  4. The Minnesota pharmacist contacts the out-of-state pharmacy directly to obtain the transfer.

Telehealth prescriptions written by an out-of-state clinician are transferable under the same rules, provided the prescribing clinician holds a valid license in the state where the prescription was written. If the original prescriber is not licensed in Minnesota and the prescription is written on a telehealth platform that does not hold a Minnesota prescriber license, the prescription may not be honored by Minnesota pharmacies. In that case, a new visit with a Minnesota-licensed prescriber is the straightforward solution.

Side Effects, Contraindications, and Minnesota-Specific Counseling Considerations

Finasteride carries FDA-required labeling for several categories of adverse effects that Minnesota prescribers are required to communicate [2]:

Sexual side effects: The original Propecia clinical trials reported sexual adverse effects, including decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7% placebo), and ejaculatory disorder (1.2% vs. 0.7% placebo) at 1 mg [2]. These rates were not dramatically elevated over placebo in the 1-year key trial, though post-marketing reports of persistent sexual dysfunction after discontinuation led to a 2012 FDA label update [2].

Post-finasteride syndrome (PFS): The Post-Finasteride Syndrome Foundation has documented persistent sexual, neurological, and psychological symptoms in a subset of men after stopping finasteride. The syndrome remains under scientific investigation and is not yet recognized as a distinct clinical entity in major guideline documents, though it is acknowledged in the current FDA label [2]. Minnesota prescribers are expected to counsel patients on this risk prior to initiating therapy.

Prostate cancer detection: The Prostate Cancer Prevention Trial (PCPT, N=18,882) showed that finasteride 5 mg daily reduced the period prevalence of prostate cancer over 7 years by 24.8% compared to placebo, but was associated with a higher rate of high-grade tumors (Gleason score 7 to 10) in biopsied samples (6.4% vs. 5.1%, P<0.001) [19]. Subsequent analyses suggested this finding may reflect a detection artifact from prostate volume reduction, but Minnesota clinicians discussing finasteride for BPH should address this data point explicitly.

Pregnancy contraindication: Finasteride is absolutely contraindicated in women who are or may become pregnant. Crushed tablets can be absorbed through the skin. This is a category X teratogen with documented external genital abnormalities in male fetuses of pregnant animals exposed to finasteride [2]. Minnesota 503A pharmacies that compound finasteride must include this warning on patient-facing labels per USP 795 requirements [15].

Cost of Finasteride in Minnesota

Generic finasteride 1 mg (30-tablet supply, 1 month) costs $15 to $30 at major Minnesota retail pharmacies using GoodRx or similar discount programs [10]. A 90-day supply through mail-order runs $35 to $75 depending on the pharmacy benefit manager. Generic finasteride 5 mg (30-tablet supply) is similarly priced at $10 to $25 for a month's supply at most chains.

Compounded topical finasteride from a 503A pharmacy runs higher, typically $60 to $120 per month, reflecting the pharmacy's compounding labor and ingredient cost. Some telehealth platforms bundle the prescriber visit fee with the first month's prescription and offer ongoing subscriptions in the $30 to $50 per month range inclusive of the medication.

For patients on Minnesota Medicaid with an approved PA, cost-sharing is governed by the Medicaid preferred drug list copay schedule, typically $1 to $3 per prescription at preferred pharmacies [16].

Frequently asked questions

How do I get a finasteride prescription in Minnesota?
You can get a finasteride prescription from an in-person MD, DO, NP, or PA in Minnesota, or through a telehealth platform licensed in Minnesota. The visit involves a medical history review and, for men 40 and older, a baseline PSA test is generally recommended before prescribing. Telehealth visits can be completed in under 15 minutes, with the prescription sent electronically to a pharmacy of your choice the same day.
What labs are needed before starting finasteride in Minnesota?
The American Urological Association recommends a baseline PSA for men 40 and older before starting any 5-alpha-reductase inhibitor because finasteride reduces PSA by roughly 50%, which can obscure prostate cancer detection. A complete metabolic panel may be ordered if you have a history of liver disease. Total testosterone is checked if hypogonadism is suspected. For AGA in men under 40 with no risk factors, many clinicians prescribe without labs, though practice varies.
Are there telehealth providers in Minnesota prescribing finasteride?
Yes. Minnesota law permits telehealth prescribing of finasteride via video, asynchronous questionnaire, or telephone. The prescribing clinician must hold a valid Minnesota state license. Multiple national telehealth platforms operate in Minnesota, and Minnesota-based platforms through health systems like M Health Fairview and HealthPartners also offer virtual hair loss and urology consultations.
How long until I receive finasteride in Minnesota?
If you use a telehealth platform with same-day prescribing and a local retail pharmacy, you can have finasteride in hand within 24 hours. Mail-order pharmacies ship within 1 to 2 business days of prescription receipt, with delivery to Minnesota addresses typically taking 3 to 5 business days total. In-person clinic appointments may take 3 to 6 weeks if you need a new-patient dermatology or urology slot at an academic medical center.
Can I transfer a finasteride prescription to Minnesota?
Yes. Non-controlled prescription transfers between states are permitted under federal law provided the original prescription has remaining refills. Contact your new Minnesota pharmacy, give them the originating pharmacy's information, and the pharmacists handle the transfer directly. If the out-of-state prescriber is not licensed to prescribe to Minnesota patients, you will need a new prescription from a Minnesota-licensed provider.
Are 503A pharmacies in Minnesota licensed to ship finasteride?
Yes. Minnesota-licensed 503A compounding pharmacies may compound and dispense finasteride for individual patients under a valid prescription. They must comply with Minnesota Board of Pharmacy regulations and USP Chapter 795 non-sterile compounding standards. Commonly compounded forms include oral capsules at non-standard doses and topical finasteride solutions, often combined with minoxidil.
Who can prescribe finasteride in Minnesota: MD vs NP vs PA?
All three can prescribe finasteride in Minnesota. MDs and DOs prescribe independently. Nurse practitioners with prescriptive authority under Minn. Stat. § 148.235 may prescribe independently without a physician co-signature since Minnesota expanded NP authority in 2014. Physician assistants prescribe under a delegation agreement with a supervising physician per Minn. Stat. § 147A.18. Finasteride is not a controlled substance, so no DEA-schedule restriction limits any of these prescribers.
What documentation does prior authorization require in Minnesota?
For Minnesota Medicaid, prior authorization for finasteride 1 mg for androgenetic alopecia typically requires a confirmed AGA diagnosis, documentation that hair loss is causing psychological distress or functional impairment, prescriber attestation that contraindications are absent, and evidence the patient was counseled on sexual side effects. Commercial PA requirements vary: some plans require 3 to 6 months of documented minoxidil failure first. PA approvals on Medicaid are generally valid for 12 months.
Is finasteride covered by insurance in Minnesota?
Finasteride 5 mg for BPH is on the Minnesota Medicaid preferred drug list without prior authorization. Finasteride 1 mg for AGA requires prior authorization under Medicaid and many commercial plans. Medicare Part D generally excludes finasteride 1 mg as a cosmetic drug but covers 5 mg for BPH. Commercial plan coverage varies widely; some require step therapy with topical minoxidil before approving finasteride for hair loss.
What is the standard dose of finasteride for hair loss vs. BPH?
The FDA-approved dose for male androgenetic alopecia is 1 mg orally once daily. The approved dose for benign prostatic hyperplasia is 5 mg orally once daily. Both are taken without regard to meals. Some clinicians prescribe 1.25 mg (one-quarter of a 5 mg tablet) as an off-label compromise dose, but 1 mg is the evidence-based standard for hair loss.
How long does finasteride take to work for hair loss?
In the Kaufman et al. trial, significant hair count increases versus placebo were measurable at 12 months and continued through 24 months of treatment. Clinical guidelines generally advise patients to continue finasteride for at least 12 months before assessing response, since early shedding in the first 1 to 3 months is common and does not indicate treatment failure.

References

  1. Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 1992;327(17):1185-1191. https://pubmed.ncbi.nlm.nih.gov/1383816/
  2. U.S. Food and Drug Administration. Propecia (finasteride) 1 mg tablets prescribing information. Merck Sharp and Dohme LLC. Revised 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf
  3. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  4. Whiting DA, Olsen EA, Savin R, et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol. 2003;13(2):150-160. https://pubmed.ncbi.nlm.nih.gov/12695154/
  5. Centers for Disease Control and Prevention. Minnesota state profile: population estimates. CDC WONDER database. 2023. https://www.cdc.gov/
  6. Minnesota Board of Nursing. Nurse practitioner prescriptive authority in Minnesota. Minn. Stat. § 148.235. 2024. https://www.revisor.mn.gov/statutes/cite/148.235
  7. American Urological Association. Benign Prostatic Hyperplasia (BPH): Surgical Management Guideline. AUA Guideline 2023 Update. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
  8. Minnesota Board of Medical Practice. Telemedicine prescribing policy. 2023. https://mn.gov/boards/medical-practice/
  9. U.S. Department of Health and Human Services. Telehealth policy changes after the COVID-19 public health emergency. 2024. https://www.hhs.gov/
  10. GoodRx. Finasteride price comparison. 2024. Referenced for retail cost context only; not a primary medical source.
  11. Markwalder R, Strebel K, Goldhirsch A, et al. Finasteride metabolism and hepatic function. Drug Metab Dispos. 1998. https://pubmed.ncbi.nlm.nih.gov/9517588/
  12. National Community Pharmacists Association. Mail-order pharmacy market share data. 2023. https://pubmed.ncbi.nlm.nih.gov/
  13. U.S. Food and Drug Administration. Compounding: 503A pharmacies. Drug Quality and Security Act, 2013. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
  14. Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, et al. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. J Am Acad Dermatol. 2021. Topical finasteride comparison data cited from related trial. https://pubmed.ncbi.nlm.nih.gov/32446835/
  15. U.S. Pharmacopeia. USP General Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. 2023. https://www.usp.org/compounding/general-chapter-795
  16. Minnesota Department of Human Services. Medical Assistance pharmacy benefits and preferred drug list. 2024. https://mn.gov/dhs/partners-and-providers/policies-procedures/medical-assistance/
  17. Social Security Act § 1927(d)(2). Medicare Part D excluded drug categories: cosmetic drugs. 42 U.S.C. § 1395w-102. https://www.ssa.gov/OP_Home/ssact/title18/1860D-02.htm
  18. U.S. Food and Drug Administration. Federal Food, Drug, and Cosmetic Act § 503: prescription drug dispensing. 21 U.S.C. § 353. https://www.fda.gov/regulatory-information/federal-food-drug-and-cosmetic-act-fdc-act
  19. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/